Josh Hardman, BSc

Founder & Editor
Psychedelic Alpha
Harrogate, England, United Kingdom

Josh Hardman is the Founder & Editor of Psychedelic Alpha, an independent platform covering psychedelic drug development, regulation, and access.

The platform is read by biotech and pharma executives, investors and philanthropists, policymakers and advocates, clinicians and practitioners, and researchers and scientists seeking sober, data-driven coverage of the sector.

Beyond publishing, Josh advises companies and organizations on matters including strategy, positioning, and fundraising strategy through Psychedelic Alpha's consultancy and advisory arm.

Presentation(s):

• F14 - Psychedelics: State of the Union

  Tuesday, April 28, 2026
  4:00 PM - 5:00 PM MDT